Hybrid Inhibitors of Phosphatidylinositol 3-Kinase (PI3K) and the Mammalian Target of Rapamycin (mTOR): Design, Synthesis, and Superior Antitumor Activity of Novel Wortmannin−Rapamycin Conjugates
Author:
Affiliation:
1. Discovery Medicinal Chemistry
2. Preclinical Development
3. Discovery Oncology
4. Drug Metabolism
5. Chemical Technologies
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm901427g
Reference27 articles.
1. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
3. The PTEN–PI3K pathway: of feedbacks and cross-talks
4. The Pharmacology of mTOR Inhibition
5. Targeting the mTOR Signaling Network for Cancer Therapy
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Wortmannin Inhibits Cell Growth and Induces Apoptosis in Colorectal Cancer Cells by Suppressing the PI3K/AKT Pathway;Anti-Cancer Agents in Medicinal Chemistry;2024-07
2. Nanoscale metal-organic framework delivers rapamycin to induce tissue immunogenic cell death and potentiates cancer immunotherapy;Nanomedicine: Nanotechnology, Biology and Medicine;2023-06
3. I2-DMSO mediated N1/C5 difunctionalization of anthranils with aryl methyl ketones: A facile access to multicarbonyl compounds;Tetrahedron;2022-11
4. Discovery and Development of Macrolides as Anticancer Agents;Current Topics in Medicinal Chemistry;2021-07
5. Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?;Molecules;2021-04-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3